AlphaMaven AlphaMaven

From Venture Capital, IPOs and M&A Deals at Morgan Stanley and Merrill Lynch to Investing in People

Reported by Taipeitimes
Jul 15, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Morgan Stanley led 7 U.S. technology IPOs in 2025 as Lead Left Bookrunner, raising $6.2 billion collectively, including marquee names Figma, Chime, Omada, MNTN, Hinge Health, and CoreWeave.
  • • Morgan Stanley's wealth management division expanded pre-IPO share trading capabilities to provide high-net-worth clients direct access to private company equity before public market listings.
  • • Morgan Stanley Investment Management deepened its alternative investment footprint through expanded partnership with iCapital, extending private markets fund access to wealth managers globally.
  • • The firm positions itself as a comprehensive platform connecting portfolio companies with operational expertise, industry thought leadership, and managerial talent through its Next Level strategic initiative.
  • • Capital markets activity, including M&A and IPOs, is experiencing resurgence momentum heading into 2025-2026, with Morgan Stanley research analysts highlighting structural drivers of market recovery.
Summary
Morgan Stanley strengthened its position as a leading technology IPO advisor in 2025, serving as Lead Left Bookrunner on seven U.S. technology offerings that collectively raised $6.2 billion. The portfolio includes prominent exits: Figma, Chime, Omada Health, MNTN (Mountain), Hinge Health, and CoreWeave. This track record reflects sustained demand for growth-stage technology liquidity events and underscores Morgan Stanley's competitive positioning in the capital markets advisory space during a period of renewed IPO activity.

The firm has simultaneously expanded its alternative investment distribution capabilities. Morgan Stanley Investment Management extended its partnership with iCapital, a leading private markets platform, to deliver enhanced access to private market funds for wealth managers globally. This strategic expansion addresses institutional and high-net-worth demand for diversified alternative asset exposure and positions Morgan Stanley to capture a growing share of alternative investment allocation flows.

Morgan Stanley's wealth management arm introduced pre-IPO share trading services for its client base, enabling portfolio company employees and sophisticated investors to transact in private company equity prior to public market debuts. This offering capitalizes on the firm's dual positioning across corporate advisory and wealth management, creating a competitive moat in pre-liquidity event trading.

The firm's "Next Level" strategic initiative encapsulates a broader ecosystem approach, providing portfolio companies with structured access to Morgan Stanley's thought leadership, industry experts, operational resources, and managerial talent. This value-add positioning differentiates the firm beyond traditional capital markets transactional services and reflects evolving client expectations for comprehensive strategic partnerships.

Morgan Stanley research analysts, including Michelle Weaver, Michael Cyprys, and Ryan Kenny, have articulated bullish perspectives on capital markets recovery, emphasizing structural drivers supporting IPO and M&A resurgence in 2024-2025. Historical data points to 1,073 IPOs in 2021 raising $317 billion, providing benchmark context for recovery trajectory assessment.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Taipeitimes From Venture Capital, IPOs and M&A Deals at Morgan Stanley and Merrill Lynch to Investing in People